BVF Inc’s Immunic IMUX Stock Holding History

BVF Inc’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.49M	Hold	765,297	–	–	0.27%	34
2025 Q4	$4.08M	Hold	765,297	–	–	0.14%	39
2025 Q3	$6.75M	Hold	765,297	–	–	0.27%	37
2025 Q2	$5.34M	Sell	765,297 -125,000	-14%	-$1.15M	0.19%	36
2025 Q1	$9.7M	Hold	890,297	–	–	0.4%	34
2024 Q4	$8.9M	Hold	890,297	–	–	0.3%	39
2024 Q3	$14.7M	Hold	890,297	–	–	0.43%	34
2024 Q2	$9.88M	Hold	890,297	–	–	0.28%	38
2024 Q1	$11.8M	Buy	+890,297	New	+$11.6M	0.32%	39
2023 Q4	–	Sell	-114,943	Closed	-$1.69M	–	72
2023 Q3	$1.69M	Hold	114,943	–	–	0.05%	66
2023 Q2	$2.89M	Hold	114,943	–	–	0.08%	60
2023 Q1	$1.71M	Hold	114,943	–	–	0.06%	66
2022 Q4	$1.61M	Buy	+114,943	New	+$3.13M	0.07%	68

Other funds holding IMUX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

BVF Inc's IMUX Position: Q1 2026 in Review

BVF Inc held its Immunic (IMUX) position steady in Q1 2026 at 765,297 shares worth $8.49M. The position accounts for 0.27% of the portfolio, ranked #34.

BVF Inc first reported a position in IMUX in Q4 2022 and has held it in 13 quarters since. The position peaked at $14.7M in Q3 2024. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

BVF Inc held 765,297 shares of Immunic worth $8.49M as of Q1 2026.
BVF Inc left its Immunic share count unchanged in Q1 2026.
Immunic made up 0.27% of BVF Inc's portfolio in Q1 2026, its #34 holding.
BVF Inc first reported a position in Immunic in Q4 2022 and has held it in 13 quarters since.
BVF Inc's Immunic position peaked at $14.7M in Q3 2024.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.